Innovating for Canadians

Our desire to help Canadians live longer, healthier lives drives us to innovate across multiple therapeutic areas. The deep expertise EMD Serono brings to fertility, endocrinology, neurology and immunology helps make a real difference to patients. Our portfolio includes medicines to treat cancers, multiple sclerosis, infertility and growth disorders.


For more than 30 years, we have dedicated ourselves to responding to the unmet medical needs of Canadian patients. This is what inspires our employees from across the country in their work across all disciplines, including medical affairs, regulatory affairs, drug safety and medical information, quality assurance, sales and marketing, patient access, compliance and patient support.

We are a team of curious minds working together to expand and evolve therapeutic pipelines in our focus areas of oncology, neurology, fertility and endocrinology. We encourage each other to pursue innovation to its highest potential to improve the lives of people in Canada who are challenged by their disease.

For three decades we’ve been putting patients first in developing high-quality treatment options. Our high-performing, diverse pipeline speaks to the quality of work and talent of the Canadian team. We’ll continue to make the strong connections to evolve our therapies and aspire to help Canadians enjoy healthier, happier lives.

Javed Alam

President and Managing Director

EMD Serono, Canada

EMD Inc. Canadian Head Office

An affiliate of Merck KGaA, Darmstadt, Germany

2695 North Sheridan Way
Suite 200 Mississauga
ON L5K2N6, Canada
43.5124856 -79.6659206